These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23123021)

  • 1. High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.
    Chen X; Pravetoni M; Bhayana B; Pentel PR; Wu MX
    Vaccine; 2012 Dec; 31(1):159-64. PubMed ID: 23123021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates.
    McCluskie MJ; Pryde DC; Gervais DP; Stead DR; Zhang N; Benoit M; Robertson K; Kim IJ; Tharmanathan T; Merson JR; Davis HL
    Int Immunopharmacol; 2013 May; 16(1):50-6. PubMed ID: 23562759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction.
    Zhao Z; Harris B; Hu Y; Harmon T; Pentel PR; Ehrich M; Zhang C
    Biomaterials; 2018 Feb; 155():165-175. PubMed ID: 29179132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like Receptor 9 Agonists as Adjuvants for Nanoparticle-Based Nicotine Vaccine.
    Hu Y; Smith D; Frazier E; Zhao Z; Zhang C
    Mol Pharm; 2021 Mar; 18(3):1293-1304. PubMed ID: 33497574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser vaccine adjuvant for cutaneous immunization.
    Chen X; Wu MX
    Expert Rev Vaccines; 2011 Oct; 10(10):1397-403. PubMed ID: 21988305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-fractional epidermal powder delivery for improved skin vaccination.
    Chen X; Kositratna G; Zhou C; Manstein D; Wu MX
    J Control Release; 2014 Oct; 192():310-6. PubMed ID: 25135790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Monophosphoryl Lipid A (MPL), CpG Oligodeoxynucleotide (ODN), and QS-21 Adjuvants Induces Strong and Persistent Functional Antibodies and T Cell Responses against Cell-Traversal Protein for Ookinetes and Sporozoites (CelTOS) of Plasmodium falciparum in BALB/c Mice.
    Pirahmadi S; Zakeri S; Mehrizi AA; Djadid ND; Raz AA; Sani JJ
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936155
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle.
    Hu Y; Zheng H; Huang W; Zhang C
    Hum Vaccin Immunother; 2014; 10(1):64-72. PubMed ID: 24091786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing nicotine vaccine immunogenicity with liposomes.
    Lockner JW; Ho SO; McCague KC; Chiang SM; Do TQ; Fujii G; Janda KD
    Bioorg Med Chem Lett; 2013 Feb; 23(4):975-8. PubMed ID: 23313243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.
    Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C
    Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy.
    Cornish KE; Harris AC; LeSage MG; Keyler DE; Burroughs D; Earley C; Pentel PR
    Int Immunopharmacol; 2011 Nov; 11(11):1809-15. PubMed ID: 21802529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum.
    de Villiers SH; Cornish KE; Troska AJ; Pravetoni M; Pentel PR
    Vaccine; 2013 Dec; 31(52):6185-93. PubMed ID: 24176492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New directions in nicotine vaccine design and use.
    Pentel PR; LeSage MG
    Adv Pharmacol; 2014; 69():553-80. PubMed ID: 24484987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditions.
    Cornish KE; de Villiers SH; Pravetoni M; Pentel PR
    PLoS One; 2013; 8(12):e82557. PubMed ID: 24312662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the protective effects of a conformationally constrained nicotine vaccine.
    Moreno AY; Azar MR; Koob GF; Janda KD
    Vaccine; 2012 Oct; 30(47):6665-70. PubMed ID: 22963803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy.
    Zhao Z; Hu Y; Hoerle R; Devine M; Raleigh M; Pentel P; Zhang C
    Nanomedicine; 2017 Feb; 13(2):443-454. PubMed ID: 27520729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers.
    Hatsukami DK; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR
    Clin Pharmacol Ther; 2005 Nov; 78(5):456-67. PubMed ID: 16321612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL).
    Lodmell DL; Ray NB; Ulrich JT; Ewalt LC
    Vaccine; 2000 Jan; 18(11-12):1059-66. PubMed ID: 10590326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats.
    Roiko SA; Harris AC; Keyler DE; Lesage MG; Zhang Y; Pentel PR
    J Pharmacol Exp Ther; 2008 Jun; 325(3):985-93. PubMed ID: 18305013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.
    Kim SK; Ragupathi G; Cappello S; Kagan E; Livingston PO
    Vaccine; 2000 Oct; 19(4-5):530-7. PubMed ID: 11027818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.